Intrinsic Value of S&P & Nasdaq Contact Us

Agilent Technologies, Inc. A NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
74/100
5/7 Pass
SharesGrow Intrinsic Value
$120.45
+0%
Analyst Price Target
$168.18
+39.7%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Agilent Technologies, Inc. (A) has shown moderate revenue growth over the past 3 years, expanding from $6.8B to $6.9B (average +0.6%/yr). Net income reached $1.3B, reflecting modest earnings improvement at +1.3%/yr on average. The net profit margin is 18.8%, which is high. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 52.4% (high), with a -2pp trend over the period. With a $34B market cap and MOAT composite score of 76/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (45/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 28-year history, the company was profitable in 25 of 28 years — a solid long-term record with occasional losses
  • INCOME (70/100, Pass) — proves strong profitability and pricing power
  • MOAT (76/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 74/100 with 5/7 criteria passed.

74/100
SG Score
View full scorecard →
~
VALUE
58/100
Price-to-Earnings & upside
→ IV page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $4.57
Proven by this page
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
76/100
Score: 76/100
GM 52.4% (-2pp)
Proven by this page
~
GROWTH
45/100
Rev +0.6%/yr
NI +1.3%/yr
Proven by this page
INCOME
70/100
Margin 18.8%
$6.9B
Proven by this page
Agilent Technologies, Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $7.07B$6.95B$6.51B$6.83B$6.85B
Gross Profit $3.69B$3.64B$3.54B$3.47B$3.72B
Gross Margin 52.2%52.4%54.3%50.7%54.4%
Operating Income $1.46B$1.48B$1.49B$1.35B$1.62B
Net Income $1.29B$1.3B$1.29B$1.24B$1.25B
Net Margin 18.3%18.8%19.8%18.1%18.3%
EPS (Diluted) $4.53$4.57$4.43$4.19$4.18
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message